Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Transforming gliobastoma treatment: Imvax closes $112m Series C round
  2. Revitope and Junshi collaborate on improved T-cell engager antibodies
  3. Sanofi licenses Kiadis’s modified NK cell therapy for multiple myeloma
  4. Charting the history of immunotherapy, cancer treatment’s fourth pillar
  5. Breaking the blood brain barrier: neurology’s greatest challenge

Latest Content

Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa’s Second Covid-19 Therapeutic Development Programme

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been contracted to conduct a clinical study of Atossa Therapeutics’ proprietary drug candidate AT-301, to be administered by nasal spray. Avance has successfully completed multiple clinical studies of Atossa’s proprietary Endoxifen.

Economic Magnet Seal 2020

In June, Peter Huber Kältemaschinenbau AG from Offenburg was presented with the "Economic Magnet" seal, awarded to organisations who exhibit strong performance in seven indicative areas.

What is the Difference between Translation and Interpreting?

Usually, people who are not a part of the translation industry are not familiar with the differences between translation and interpreting and would need some clarification by a professional before deciding what they do need in terms of linguistic services.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top